Current Issue
September 2022, Volume 41, Issue 6
The September 2022 issue had a Special Section on ‘Qualitative insights on alcohol and other drug consumption during COVID-19’. This included an editorial and papers on: examining complex changes in drinking practices during COVID-19; push and pull factors shaping domestic alcohol consumption during the COVID-19 pandemic UK Spring 2020 lockdown; Australian parents' perceptions of their children's awareness of drinking during COVID-19; the pleasures and constraints of digitally-mediated alcohol and other drug consumption; and health service utilisation and access for people who inject drugs during COVID-19.
Systematic reviews discussed guidelines for managing physical health during treatment for substance use disorders; motives for the use of serotonergic psychedelics; and community-based models of alcohol and other drug support for First Nations peoples in Australia. Other research in this issue included focussed on barriers to help-seeking among music festival attendees in New South Wales, Australia; alcohol-related liver disease mortality and missed opportunities in secondary care; exploring the medical cannabis prescribing behaviours of New Zealand physicians; a brief report and case series on Kamini; drink driving among Aboriginal and Torres Strait Islander Australians; the role of Aboriginal and Torres Strait Islander families in methamphetamine use harm reduction and their own support needs; the feasibility of a drug consumption room in the Australian Capital Territory; whether different actors submit different evidence to alcohol advertising policy consultations; illicit drug use and male barroom aggression among members of the Australian construction industry; and a comment on participant reimbursement within Australian drug and alcohol research.
Cannabis legalisation and its impact on access, use and public perceptions
Follow Drug and Alcohol Review on Twitter
What's new on Early View?
The latest COVID-19 research is available online.
Comprehensive Reviews
Exploring the lived experiences of Indigenous Australians within the context of alcohol and other drugs treatment services: A scoping review
Airin Heath, Mary Kristienne Martin, Jacynta Krakouer
23 August 2022 | DOI: https://doi.org/10.1111/dar.13528
Determining a dosage threshold of drink-driving enforcement operations: A systematic review
Sharon E. O'Hara, Mallie J. Paschall, Denise A. Herd
27 July 2022 | DOI: https://doi.org/10.1111/dar.13519
Pharmacological treatment for methamphetamine withdrawal: A systematic review and meta-analysis of randomised controlled trials
Liam S. Acheson, Benjamin H. Williams, Michael Farrell, Rebecca McKetin, Nadine Ezard, Krista J. Siefried
21 July 2022 | DOI: https://doi.org/10.1111/dar.13511
Original Papers
Age at first alcohol-related hospital separation or emergency department presentation and rate of re-admission: A retrospective data linkage cohort of young Australians
Wing S. Yuen, Janni Leung, Nicola Man, Vivian Chiu, Natasa Gisev, Michael Livingston, Louisa Degenhardt, Michael Farrell, Sallie-Anne Pearson, Timothy Dobbins, Adrian Dunlop, Richard P. Mattick, Amy Peacock
23 August 2022 | DOI: https://doi.org/10.1111/dar.13529
Acute injection-related infections requiring hospitalisation among people who inject drugs: Clinical features, microbiology and management
Freya J. Langham, Stephanie J. Curtis, Mei Jie Tang, Bismi Jomon, Joseph S. Doyle, Olga Vujovic, Andrew J. Stewardson
22 August 2022 | DOI: https://doi.org/10.1111/dar.13525
‘Trial by fire’: An online survey exploring confidence of junior doctors in managing toxicology presentations to the emergency department
Jennifer L. Smith, David McCutcheon, Courtney Weber, Jessamine Soderstrom, Jonathon Burcham, Daniel M. Fatovich
18 August 2022 | DOI: https://doi.org/10.1111/dar.13526
Native Hawaiian/Pacific Islander alcohol, tobacco and other drug use, mental health and treatment need in the United States during COVID-19
Andrew M. Subica, Erick G. Guerrero, Tammy K. K. Martin, Scott K. Okamoto, Nia Aitaoto, Howard B. Moss, Brittany N. Morey, Li-Tzy Wu
11 August 2022 | DOI: https://doi.org/10.1111/dar.13522
Navigating the grey: Experiences of incremental cannabis reform in Australia
Liz Barrett, Richard Mellor, Alison Ritter, Laura McLauchlan, Matthew Kearnes
1 August 2022 | DOI: https://doi.org/10.1111/dar.13518
Is a brain-based understanding of addiction predominant? An assessment of addiction researchers' conceptions of addiction and their evaluation of brain-based explanations
Doris Ochterbeck, Sarah Forberger
1 August 2022 | DOI: https://doi.org/10.1111/dar.13520
Association of combustible and non-combustible tobacco use with clinically diagnosed adverse oral health outcomes among US adults, National Health and Nutrition Examination Survey (2009–2014)
Onyema G. Chido-Amajuoyi, Onyinye Omega-Njemnobi, Chimuanya Okoli, Chamberline Ozigbu, Ibeawuchi Okoroafor, Nnabuchi Anikpezie, Satomi Odani, Israel Agaku
27 July 2022 | DOI: https://doi.org/10.1111/dar.13510
Substance use in the emergency department: Screening for risky drug use, using the ASSIST-Lite
Matthew W. R. Stevens, Jennifer Harland, Sam Alfred, Robert L. Ali
22 July 2022 | DOI: https://doi.org/10.1111/dar.13513
Written information and health professionals are the information sources about alcohol use in pregnancy most often used by pregnant women
Tracey W. Tsang, Melanie Kingsland, Emma Doherty, Amy E. Anderson, Belinda Tully, Sarah Ward, John Wiggers, Elizabeth J. Elliott
14 July 2022 | DOI: https://doi.org/10.1111/dar.13512
Impact of the ‘10,000 lives’ program on Quitline referrals, use and outcomes by demography and Indigenous status
Arifuzzaman Khan, Kalie Green, Linda Medlin, Gulam Khandaker, Sheleigh Lawler, Coral Gartner
13 July 2022 | DOI: https://doi.org/10.1111/dar.13499
The alcohol self-presentation model: Using thematic qualitative analysis to elucidate how college students self-present via alcohol-related social media posts
Mai-Ly N. Steers, Lene C. Mannheim, Rose Marie Ward, Angela B. Tangyin
28 June 2022 | DOI: https://doi.org/10.1111/dar.13508
Association between perceived addiction and cessation behaviours among users of smokeless or combustible tobacco in India
Vaibhav P. Thawal, Flora Tzelepis, Sima Ahmadi, Christine Paul
28 June 2022 | DOI: https://doi.org/10.1111/dar.13507
Commentaries
Nicotine vaping was not the cause of e-cigarette, or vaping, product use-associated lung injury in the United States
Colin P. Mendelsohn, Alex Wodak, Wayne Hall
23 August 2022 | DOI: https://doi.org/10.1111/dar.13533
Walking side-by-side: Supporting Aboriginal and Torres Strait Islander Australians to lead the way in alcohol research
K. S. Kylie Lee, Scott Wilson, Annalee E. Stearne, Noel Hayman, James H. Conigrave, Michael Doyle, Lynette Bullen, Teagan J. Weatherall, Doug James, Taleah Reynolds, Jimmy Perry, Katherine M. Conigrave, On behalf of Members, Investigators, Indigenous Advisory Group and staff of the Centre of Research Excellence in Indigenous Health and Alcohol
4 August 2022 | DOI: https://doi.org/10.1111/dar.13523
Women with alcohol dependence and FASD prevention
Susan Evans
22 July 2022 | DOI: https://doi.org/10.1111/dar.13516
A critical analysis of ‘Electronic cigarettes and health outcomes: Systematic review of global evidence’
Colin Paul Mendelsohn, Alex Wodak, Wayne Hall, Ron Borland
21 July 2022 | DOI: https://doi.org/10.1111/dar.13515
Developing harm reduction policies: Evidence from Copenhagen's drug consumption rooms
Jordan M. Hyatt, Synøve N. Andersen, Emily Greberman, Lars H. Andersen, Ivan Christensen
5 July 2022 | DOI: https://doi.org/10.1111/dar.13509
Letters to the Editor
The 2022 Philippine election, mental health and the ‘war on drugs’
Alexander Smith, Maria Corazon A. De Ungria, Jose M. Jose, Michael Liebrenz
1 August 2022 | DOI: https://doi.org/10.1111/dar.13521
COVID-19 vaccination coverage, vaccine hesitancy and opioid use disorder: Correspondence
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
14 July 2022 | DOI: https://doi.org/10.1111/dar.13514
Call for Papers
A special section of Drug and Alcohol Review with articles on peer researchers; hepatitis C virus and injecting drug use; ageing and drug use; women who use drugs; parents who use drugs; and international advocacy and human rights
Drug and Alcohol Review - Clinician's Corner
Systematic review of guidelines for managing physical health during treatment for substance use disorders: Implications for the alcohol and other drug workforce
The physical health consequences of substance use disorders are well established. Among people in alcohol and other drug (AOD) treatment, addressing physical health as part of an integrated treatment response can enhance motivation to change patterns of substance use and increase physical and psychological quality of life. On the other hand, unmet health needs have been associated with dropout from treatment and an increased risk of relapse. Several challenges exist for specialist AOD treatment services in addressing the physical health of clients. This includes increasing demands on the AOD workforce – most of which are not medically trained [1,2] – to deliver treatment responses that meet the full spectrum of clients’ physical, psychological and social needs.
In this context, clinical practice guidelines are a useful and widely available resource that could support the AOD workforce when responding to the physical health needs of clients. They can facilitate the delivery of quality healthcare and enhance clinical decision-making [3]. When rigorously developed, they offer a means of translating empirical research into practice.
Thus clinical practice guidelines could guide the AOD workforce when addressing physical health comorbidities within specialist addiction treatment – though their usefulness for doing so has not previously been examined.
Through a systematic review, we synthesised the recommendations made within existing guidelines for integrating physical health care during AOD treatment. The review was not intended to prescribe what “should” be done by the AOD workforce when addressing the physical health conditions of clients. Rather we set out to clarify what the existing guidelines recommend, as a starting point for enhancing the way that physical health is managed. Specifically, we sought to answer two questions: (i) Which physical health conditions do treatment guidelines recommend addressing during AOD treatment? and (ii) What recommendations are made for the management of physical health conditions during AOD treatment?
An iterative search of grey literature was conducted from September 2020 to February 2021 to identify clinical practice guidelines. Content pertaining to physical health care during AOD treatment was extracted. The quality of guidelines was appraised using the Appraisal of Guidelines Research and Evaluation II (AGREE-II) tool.
Thirty-three guidelines were included in our review. Fourteen guidelines were considered high quality based on AGREE-II scores. Neurological conditions (90.9%) and hepatitis (81.8%) were the most frequent health problems addressed. Most guidelines recommended establishing referral pathways to address physical health comorbidities (90.9%). Critically, however, guidance on facilitating these referral pathways was less common (42.4%). We found that the guidelines were inconsistent in their recommendations related to oral health, tobacco use, physical activity, nutrition and the use of standardised assessment tools.
We concluded that greater consistency and specificity in the recommendations made for integrating physical health care within AOD treatment is needed. Ensuring that recommendations are applicable to the diverse AOD workforce and to treatment services limited by funding and resource constraints would enhance implementation. Future guideline development groups could consider increased consultation with the AOD workforce, and inclusion of clinical tools and decision aids to facilitate referral pathways.
Briony Osborne1
Briony Larance1,2
Peter J. Kelly1,2
1School of Psychology, University of Wollongong, Wollongong, Australia
2Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, Australia
References
- Duraisingam V, Pidd K, Roche AM, O'Connor J. Satisfaction, Stress & Retention Among Alcohol & Other Drug Workers in Australia. Flinders University, Adelaide, Australia: National Centre for Education and Training on Addiction (NCETA); 2006.
- Nicholas R, Duraisingam V, Roche A, Braye K, Hodge S. Enhancing Alcohol and Other Drug Worker's Wellbeing: A Literature Review. NSW, Australia: Network of Alcohol and other Drugs Agencies and Matua Raki; 2017.
- Institute of Medicine. Clinical Practice Guidelines We Can Trust. Graham R, Mancher M, Wolman DM, Greenfield S, Steinberg E, editors. Washington, D.C., United States: National Academies Press; 2011.
Available Open Access
Osborne B, Larance B, Ivers R, Deane FP, Robinson L, Kelly PJ. Systematic review of guidelines for managing physical health during treatment for substance use disorders: Implications for the alcohol and other drug workforce. Drug Alcohol Rev 2022;41:1367-90. https://doi.org/10.1111/dar.13504